Oncology · Phase II

Top sponsors

• First People's Hospital 261 programs
• Chinese Academy of 198 programs
• George Institute for 118 programs
• United Therapeutics Europe 112 programs
• Telethon Foundation 91 programs
• Takeda 79 programs
• Regeneron UK 71 programs
• MSD Merck Sharp 63 programs
• Ningbo Cancer Hospital 62 programs
• Anaxis Pharma 57 programs
• AstraZeneca 52 programs
• HOFFMANN-LA ROCHE 50 programs

1. Anrotinib plus Tirelizumab

   Xiyuan Hospital of China Academy of Chinese Medical Sciences

   Nasopharyngeal Carcinoma

   phase 2 · small molecule · active

   1 trial →

2. Anti-BCMA-CAR-transduced T cells

   Xiyuan Hospital of China Academy of Chinese Medical Sciences

   Leukemia

   phase 2 · mab · active

   1 trial →

3. Anti-CD19 CAR-T

   The First People's Hospital of Lianyungang

   Acute Lymphoblastic Leukemia ,Lymphomas

   phase 2 · mab · active

   1 trial →

4. Anti-CD19 CAR-T cells and Anti-CD20 CAR-T cells

   Xiyuan Hospital of China Academy of Chinese Medical Sciences

   Lymphoma, Large B-Cell, Diffuse

   phase 2 · mab · active

   1 trial →

5. Anti-CD20-CAR-transduced T cells

   Xiyuan Hospital of China Academy of Chinese Medical Sciences

   Leukemia

   phase 2 · mab · active

   1 trial →

6. Anti-CD30-CAR-transduced T cells

   Xiyuan Hospital of China Academy of Chinese Medical Sciences

   Leukemia

   phase 2 · mab · active

   1 trial →

7. Anti-CD40 Agonist Monoclonal Antibody CDX-1140

   United Therapeutics Europe Ltd

   Ovarian Clear Cell Adenocarcinoma

   phase 2 · mab · active

   1 trial →

8. Anti-HER2 CAR-T

   Xiyuan Hospital of China Academy of Chinese Medical Sciences

   Breast Cancer

   phase 2 · mab · terminated

   1 trial →

9. Anti-PD-1 antibody

   Xiyuan Hospital of China Academy of Chinese Medical Sciences

   Gastric or Gastroesophageal Junction Adenocarcinoma

   phase 2 · small molecule · active

   1 trial →

10. Anvumetostat

    Amgen

    Advanced MTAP-null Solid Tumors

    phase 2 · small molecule · active

    1 trial →

11. Apalutamide

    Janssen Cilag International NV

    Salivary Gland Neoplasms

    phase 2 · small molecule · active

    1 trial →

12. Apatinib

    The First People's Hospital of Lianyungang

    Intrahepatic Cholangiocarcinoma

    phase 2 · small molecule · active

    1 trial →

13. Apatinib

    The First People's Hospital of Lianyungang

    Advanced Esophageal Squamous Carcinoma

    phase 2 · small molecule · active

    1 trial →

14. Apatinib

    The First People's Hospital of Lianyungang

    Advanced Solid Tumors

    phase 2 · small molecule · active

    1 trial →

15. Apatinib

    Chinese University of Hong Kong

    Head and Neck Neoplasms

    phase 2 · small molecule · active

    1 trial →

16. Apatinib

    The First People's Hospital of Lianyungang

    Systematic Review of the pCR Rate of Apatinib Combined With Albumin Paclitaxel and Carboplatin Regimen for Neoadjuvant Therapy of Triple-negative Breast Cancer

    phase 2 · small molecule · active

    1 trial →

17. Apatinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lung Cancer

    phase 2 · small molecule · active

    1 trial →

18. Apatinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Metastatic Gastric Adenocarcinoma

    phase 2 · small molecule · active

    1 trial →

19. Apatinib

    Hospital Authority, Hong Kong

    Soft Tissue Sarcoma, Adult, Stage II

    phase 2 · small molecule · active

    1 trial →

20. Apatinib

    The First People's Hospital of Lianyungang

    Breast Cancer

    phase 2 · small molecule · completed

    1 trial →

21. Apatinib

    The First People's Hospital of Lianyungang

    Lung Cancer

    phase 2 · small molecule · active

    1 trial →

22. Apatinib

    The First People's Hospital of Lianyungang

    Non Small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

23. Apatinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Breast Cancer Metastatic

    phase 2 · small molecule · active

    1 trial →

24. Apatinib Combined With SHR-1210 Injection

    The First People's Hospital of Lianyungang

    Hepatocellular Carcinoma

    phase 2 · small molecule · active

    1 trial →

25. Apatinib Mesylate +SHR-1210

    Chinese University of Hong Kong

    Hepatocellular Carcinoma

    phase 2 · other · active

    1 trial →

26. Apatinib mesylate tablet

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    phase 2 · small molecule · active

    1 trial →

27. Apatinib mesylate tablets

    The First People's Hospital of Lianyungang

    Gastric Cancer

    phase 2 · small molecule · active

    1 trial →

28. Apatinib+ SHR-1210（Camrelizumab）

    The First People's Hospital of Lianyungang

    Esophageal Cancer

    phase 2 · small molecule · active

    1 trial →

29. Apheresis and Bridging Therapy

    The First People's Hospital of Lianyungang

    Large B-cell Lymphoma

    phase 2 · other · completed

    1 trial →

30. Ara-C Group

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia

    phase 2 · small molecule · active

    1 trial →

31. Arm 1： Standard Synchronous Group

    The First People's Hospital of Lianyungang

    Advanced Non-Small Cell Lung Cancer (NSCLC)

    phase 2 · small molecule · active

    1 trial →

32. Arm A

    The First People's Hospital of Lianyungang

    Esophageal Cancer

    phase 2 · small molecule · active

    1 trial →

33. Arm1

    Hospital Authority, Hong Kong

    Oral Squamous Cell Carcinoma

    phase 2 · small molecule · active

    1 trial →

34. Arsenic Trioxide

    Teva Pharma GmbH

    Lung Cancer

    phase 2 · small molecule · completed

    1 trial →

35. Art-BTC

    Hospital Authority, Hong Kong

    Biliary Cancer Metastatic

    phase 2 · small molecule · active

    1 trial →

36. Asciminib, ASCIMINIB HYDROCHLORIDE

    Novartis Pharmaceuticals

    Philadelphia positive Chronic Myeloid leukemia in Chronic Phase with newly diagnosed and resistant/intolerant to previous TKIs, with or without the T315I mutation

    phase 2 · small molecule · active

    1 trial →

37. Asparaginase Erwinia chrysanthemi

    Jazz Pharmaceuticals Ireland Limited

    B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative

    phase 2 · small molecule · active

    1 trial →

38. Association atezolizumab + BDB001 + RT

    Eikon Therapeutics

    Solid Tumor, Adult

    phase 2 · small molecule · active

    1 trial →

39. Ataluren + Pembrolizumab

    PTC THERAPEUTICS, INC.

    Colorectal Cancer

    phase 2 · small molecule · active

    1 trial →

40. Atezolizumab

    Hoffmann-La Roche

    Advanced Liver Cancers

    phase 2 · small molecule · active

    1 trial →

41. Atezolizumab

    HALOZYME THERAPEUTICS, INC.

    Pancreatic Ductal Adenocarcinoma

    phase 2 · small molecule · terminated

    1 trial →

42. Atezolizumab

    Oncotelic Therapeutics

    Metastatic Lung Non-Small Cell Carcinoma

    phase 2 · mab · terminated

    1 trial →

43. Atezolizumab

    United Therapeutics Europe Ltd

    Metastatic Colorectal Carcinoma

    phase 2 · small molecule · completed

    1 trial →

44. Atezolizumab

    United Therapeutics Europe Ltd

    Locally Advanced Hepatocellular Carcinoma

    phase 2 · mab · active

    1 trial →

45. Atezolizumab

    Syndax Pharmaceuticals

    Metastatic Cancer

    phase 2 · small molecule · terminated

    1 trial →

46. Atezolizumab

    BEONE MEDICINES AUS PTY LTD

    Advanced Liver Cancers

    phase 2 · small molecule · active

    1 trial →

47. Atezolizumab

    Arcus Biosciences

    Prostate Adenocarcinoma

    phase 2 · small molecule · active

    1 trial →

48. Atezolizumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Small-cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

Frequently asked questions